Computed tomography (CT) imaging as an excellent approach to the detec
tion and characterization of small solitary pulmonary nodules (SSPN) r
aises three questions: (1) How often does CT imaging lead to detection
of SSPN? (2) How often is such an SSPN malignant? (3) If malignant, h
ow curable is it? The first question pertains to decisions about scree
ning use of CT (clinical or mass screening), the second to decisions a
bout screening for SSPN and diagnosis of malignancy given SSPN, and th
e third - in the context of known curability at ordinary clinical diag
nosis - to decisions about screening for SSPN, diagnosis given SSPN an
d intervention given malignant SSPN. We present a three component stud
y design that addresses these questions. The first is directed primari
ly to the first question. Some 1000 persons at high risk for lung canc
er will be screened for SSPN using screening-type CT. The primary aim
is to determine the prevalence of CT-detectable SSPN as a joint functi
on of risk-relevant aspects of the person. The second component addres
ses the prevalence of malignancy among the detected cases of SSPN, To
develop the prevalence function, a larger series of CT-detected SSPN w
ill be obtained by developing a multi-center SSPN ''registry'' A subse
quent, third component will focus on the registered cases of malignant
SSPN screening incidentally detected and address their curability on
the basis of long-term follow-up. This design, in lieu of a randomized
trial, may represent a new paradigm for applied research on radiologi
c technologies in cancer screening, given its advantages in terms of r
esearch efficiency and implications to decisions about diagnostic work
up and therapeutic intervention.